N-[(1-Fluorocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-N-[2-{2-[4-({4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-1-piperazinyl}methyl)phenoxy]ethoxy}-4-(4-methyl-1,3-thiazol-5-yl)benzyl]-4-hydroxy-L -prolinamide(CAS: 2375564-55-7)

The compound has a crystalline form with a molecular weight of approximately 1234.12 g/mol. It has a low solubility in water but is soluble in organic solvents. The compound is relatively stable under normal conditions but exhibits reactivity towards nucleophiles. It is a prodrug and shows potential in pharmaceutical applications.

The compound is synthesized through multi-step reactions involving protection, substitution, and coupling reactions. Commonly used catalysts include palladium complexes and acid/base catalysts. The synthetic route involves high selectivity and moderate to high yields, typically ranging from 50-70%.

The compound is primarily used in the pharmaceutical industry for its potential as a prodrug with therapeutic applications. It may also have applications in the development of new materials and sensors.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and a lab coat. Handle the compound in a fume hood to avoid inhalation. Spills should be cleaned up with appropriate solvents and materials. Refer to the safety data sheet (SDS) for detailed handling and disposal instructions.